Becton Dickinson
BDX (NYSE)
Becton Dickinson (BDX) stands out as a high-quality Dividend Aristocrat, boasting a robust economic moat and a long track record of increasing dividends for 50 consecutive years. With a dividend yield of approximately 2.02% and an impressive one-year return of 23.39%, it remains an attractive choice for income-focused investors. Analysts are optimistic, with a consensus rating of Buy and a median 12-month price target of $202, suggesting potential upside ahead.
Pros:
- Strong dividend growth history
- High-quality medical technology
Cons:
- Market volatility risk
- Potential margin pressures
Becton Dickinson (BDX) may be particularly suitable for income-focused investors seeking stability and growth, given its strong dividend history and solid financial performance. With a proven track record and positive analyst outlook, it represents a compelling option for those looking to balance income generation with capital appreciation in the healthcare sector.
